Mohammed, N., Hatem, W. (2025). The Evaluation of circulating micro RNA-21 As a potential Biochemical in Women with Breast Cancer. , 3(3), 64-80.
Nawar Sameer Mohammed; Wafaa Thaer Hatem. "The Evaluation of circulating micro RNA-21 As a potential Biochemical in Women with Breast Cancer". , 3, 3, 2025, 64-80.
Mohammed, N., Hatem, W. (2025). 'The Evaluation of circulating micro RNA-21 As a potential Biochemical in Women with Breast Cancer', , 3(3), pp. 64-80.
Mohammed, N., Hatem, W. The Evaluation of circulating micro RNA-21 As a potential Biochemical in Women with Breast Cancer. , 2025; 3(3): 64-80.
The Evaluation of circulating micro RNA-21 As a potential Biochemical in Women with Breast Cancer
2Biochemistry Department / College of Medicine/ University of Baghdad- Baghdad- Iraq
Abstract
Background: Breast carcinoma, a malignant neoplasm originating from breast tissue, exhibits a remarkable pathological diversity that underscores its complexity. However, the pathological manifestations of this disease are multifaceted, encompassing various histological subtypes and molecular classifications. In 2018, over 2 million new cases of breast cancer were estimated to occur globally, accounting for nearly 12% of all new cancer cases. Circular RNAs (microRNAs) have recently gained attention as a novel class of non-coding RNAs with diverse gene regulatory functions among the various epigenetic regulators. Subjects and methods: The study includes 100 women with age range 23 to 80 years old. They were divided into two groups: Group A include 48 women with newly diagnosis breast cancer. And group B include 52 women without breast cancer or any others cancers. Laboratory investigation included measurement of miR-21, CA 15-3, HbA1c, Lipid profile, liver function, renal function. Results: The mean ± SD for women without breast cancer was 8.64 ± 2.17, while for women with breast cancer patients, it was 46.32 ± 11.28. The p-value was 0.000, indicating statistical significance. In conclusion, our study proven an increase in micro RNA-21 with breast cancer compared to individuals without cancer. Micro RNA-21 used as biochemical marker for breast cancer. CA 15-3, also increased with the presence of breast cancer.